The present study aimed to investigate the immunohistochemical (IHC) expression of EMT markers, including E-cadherin, Vimentin, β-catenin, and SMAD4, and their association with the oncologic outcomes of CRC. This evidence concerns the gene VIM and colorectal carcinoma.